Timothy Sullivan Named 1 of 100 Notable People In Medical Device Industry
Posted on: Wednesday, 9 July 2008, 18:00 CDT
Timothy Sullivan, President and CEO of Mystic Pharmaceuticals(TM) has been recognized for his contributions to the medical device industry by the editors of Medical Device & Diagnostic Industry (MD&DI). Sullivan was selected as one of the magazine's 100 notable people in the medical device industry and was featured in cover story of the June 2008 edition of MD&DI.
Timothy Sullivan, along with John Bradley, founded Austin, Texas based Mystic Pharmaceuticals in 2003. Since founding Mystic, Sullivan has served as President and CEO, providing both business and technical leadership.
Sullivan has been a visionary entrepreneur for more than thirty years creating new technologies and companies in life sciences, energy and information technology. He is the technology innovator of Mystic's VersiDoser(TM) platform, an aseptic unit dose drug packaging and delivery system for ophthalmic and intranasal drugs, biopharmaceuticals and biologics. Mystic, along with its partners are developing pharmaceutical and biotechnology therapeutics with diverse applications ranging from glaucoma to pandemic influenza vaccines.
About Mystic Pharmaceuticals, Inc.
Mystic Pharmaceuticals(TM) is an integrated specialty pharmaceutical company based in Austin, Texas. Mystic's VersiDoser(TM) Drug Delivery Platform provides precision unit dose drug systems for pharmaceuticals, biologic agents, vaccines and other compounds for ophthalmic and intranasal applications. Mystic combines its novel drug delivery systems with a pipeline of pharmaceuticals and biologics under development by Mystic or its partners, to meet the expanding global market demand for pharmaceutical products which are lower cost, simplified in administration and provide enhanced compliance for consumers. (www.mysticpharmaceuticals.com)
Source: Business Wire
Related Articles
- B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices
- Independent Forecasts and Competitive Intelligence on Turkey's Pharmaceuticals and Healthcare Industry Out Now
- Mexico Pharmaceuticals and Healthcare Report Q2 2008 Provides Independent Forecasts and Competitive Intelligence on Mexico's Pharmaceuticals and Healthcare Industry
- New Report Provides Independent Forecasts and Competitive Intelligence on Serbia's Pharmaceuticals and Healthcare Industry
- Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) From Valeant Pharmaceuticals
- FDA Proposes Hike in Drug Industry Fees
- Poor Results for King Pharmaceuticals' Ramipril Drug
- New Survey of Drug Industry Professionals Finds Strong Support for Cloning of Human Cells
- Drug Industry Proposes Voluntary Guides for Direct-to-Consumer Ads
- Drug Industry Unveils Guidelines on Direct-to-Consumer Ads
 |
 |
User Comments (0)
RSS Feeds